Statera BioPharma (STU:7CB) Operating Cash Flow per Share : €-0.29 (TTM As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Operating Cash Flow per Share?

Statera BioPharma's operating cash flow per share for the three months ended in Sep. 2022 was €-0.02. Statera BioPharma's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2022 was €-0.29.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Statera BioPharma's Operating Cash Flow per Share or its related term are showing as below:

STU:7CB's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.4
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Statera BioPharma Operating Cash Flow per Share Historical Data

The historical data trend for Statera BioPharma's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Operating Cash Flow per Share Chart

Statera BioPharma Annual Data

Trend

Dec19

Dec20

Dec21

Operating Cash Flow per Share

-0.01

-0.16

-0.71

Statera BioPharma Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Operating Cash Flow per Share	Get a 7-Day Free Trial						-0.48	-0.18	-0.09	-	-0.02

Competitive Comparison of Statera BioPharma's Operating Cash Flow per Share

For the Biotechnology subindustry, Statera BioPharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Statera BioPharma's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Statera BioPharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Statera BioPharma's Price-to-Operating-Cash-Flow falls into.

Statera BioPharma Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Statera BioPharma's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2021 is calculated as

Operating Cash Flow per Share (A: Dec. 2021 )	=	Cash Flow from Operations (A: Dec. 2021 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2021 )
	=	-24.951	/	35.110
	=	-0.71

Statera BioPharma's Operating Cash Flow per Share for the quarter that ended in Dec. 2021 is calculated as

Operating Cash Flow per Share (Q: Sep. 2022 )	=	Cash Flow from Operations (Q: Sep. 2022 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2022 )
	=	-0.81	/	50.234
	=	-0.02

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.29

Statera BioPharma Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Statera BioPharma (STU:7CB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525

Website

https://www.staterabiopharma.com

Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines